HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats
Abstract Background Pulmonary fibrosis is characterized by the destruction of normal lung tissue and then replacement by abnormal fibrous tissue, leading to an overall decrease in gas exchange function. The effective treatment for pulmonary fibrosis remains unknown. The upstream pathogenesis of pulm...
Saved in:
Main Authors: | Rathasapa Patarat, Suchanart Chuaybudda, Sakawdaurn Yasom, Apiwat Mutirangura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-025-03522-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of Box A of HMGB1 in producing γH2AX associated DNA breaks in lung cancer
by: Sirapat Settayanon, et al.
Published: (2025-01-01) -
Biotechnological tools boost the functional diversity of DNA-based data storage systems
by: Xiaoyuan Xu, et al.
Published: (2025-01-01) -
An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
by: Kari Ann Shirey, et al.
Published: (2025-02-01) -
Analysis of Nuclear Mitochondrial DNA Segments of Nine Plant Species: Size, Distribution, and Insertion Loci
by: Young-Joon Ko, et al.
Published: (2016-09-01) -
Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth
by: Flavie Coquel, et al.
Published: (2025-01-01)